Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers

Science

Volumn 271, Issue 5253, 1996, Pages 1289-1291

  Matsumoto, Mitsuru ^a   Mariathasan, Sanjeev ^a   Nahm, Moon H ^a   Baranyay, Ferenc ^a   Peschon, Jacques J ^b   Chaplin, David D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GERMINAL CENTER; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029991923     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.271.5253.1289     Document Type: Article

References (38)

1. N L Paul and N. H. Ruddle, Annu Rev. Immunol 6, 407 (1988); B Beutler, Tumor Necrosis Factor: The Molecules and Their Emerging Role in Medicine (Raven, New York, 1992), N H. Ruddle, Curr Opin Immunol 4, 327 (1992)
2. N L Paul and N. H. Ruddle, Annu Rev. Immunol 6, 407 (1988); B Beutler, Tumor Necrosis Factor: The Molecules and Their Emerging Role in Medicine (Raven, New York, 1992), N H. Ruddle, Curr Opin Immunol 4, 327 (1992)
3. N L Paul and N. H. Ruddle, Annu Rev. Immunol 6, 407 (1988); B Beutler, Tumor Necrosis Factor: The Molecules and Their Emerging Role in Medicine (Raven, New York, 1992), N H. Ruddle, Curr Opin Immunol 4, 327 (1992)
4. J L Browning and A Ribolini, J. Immunol. 143, 1859 (1989); J. L. Browning, M. J. Androlewicz, C. F. Ware, ibid 147, 1230 (1991), J. L. Browning et al , Cell 72, 847 (1993).
5. J L Browning and A Ribolini, J. Immunol. 143, 1859 (1989); J. L. Browning, M. J. Androlewicz, C. F. Ware, ibid 147, 1230 (1991), J. L. Browning et al , Cell 72, 847 (1993).
6. J L Browning and A Ribolini, J. Immunol. 143, 1859 (1989); J. L. Browning, M. J. Androlewicz, C. F. Ware, ibid 147, 1230 (1991), J. L. Browning et al , Cell 72, 847 (1993).
7. D. W Banner et al , Cell 73, 431 (1993)
8. J L. Browning et al., J. Immunol 154, 33 (1995)
9. L A. Tartaglia and D. V. Goeddel. Immunol. Today 13, 151 (1992).
10. P D. Crowe et al, Science 264, 707 (1994).
11. P De Togni et al., ibid , p. 703, T A Banks et al , J. Immunol. 155, 1685 (1995).
12. P De Togni et al., ibid , p. 703, T A Banks et al , J. Immunol. 155, 1685 (1995).
13. 2 in methanol. Sections were stained by first incubating with PNA-biotin (Vector) and with rat antiserum produced to IgD (Southern Biotechnology). After washing, the sections were further incubated with streptavidin conjugated with alkaline phosphatase (AP) (Zymed) and rabbit antibody to rat IgG conjugated with horseradish peroxidase (HRP) (Southern Biotechnology). Color development for bound AP and HRP was with an AP reaction kit (Vector) and with diaminobenzidine. Sections were then counterstained with 1% methyl green.
14. M. L. Rose, M. S. C. Birbeck, V J. Wallis, J. A Forrester, A J Davies, Nature 284, 364 (1980)
15. T. Hakoshima and K Tomita, J. Mol. Biol. 201, 455 (1988); E. Y Jones, D I Stuart, N. P C Walker, Nature 338, 225 (1989); M. J Eck and S. R Sprang, J Biol. Chem. 264, 17595 (1989); M. J. Eck, M. Ultsch, E. Rinderknecht, A. M. de Vos, S. R. Sprang, ibid 267, 2119 (1992).
16. T. Hakoshima and K Tomita, J. Mol. Biol. 201, 455 (1988); E. Y Jones, D I Stuart, N. P C Walker, Nature 338, 225 (1989); M. J Eck and S. R Sprang, J Biol. Chem. 264, 17595 (1989); M. J. Eck, M. Ultsch, E. Rinderknecht, A. M. de Vos, S. R. Sprang, ibid 267, 2119 (1992).
17. T. Hakoshima and K Tomita, J. Mol. Biol. 201, 455 (1988); E. Y Jones, D I Stuart, N. P C Walker, Nature 338, 225 (1989); M. J Eck and S. R Sprang, J Biol. Chem. 264, 17595 (1989); M. J. Eck, M. Ultsch, E. Rinderknecht, A. M. de Vos, S. R. Sprang, ibid 267, 2119 (1992).
18. T. Hakoshima and K Tomita, J. Mol. Biol. 201, 455 (1988); E. Y Jones, D I Stuart, N. P C Walker, Nature 338, 225 (1989); M. J Eck and S. R Sprang, J Biol. Chem. 264, 17595 (1989); M. J. Eck, M. Ultsch, E. Rinderknecht, A. M. de Vos, S. R. Sprang, ibid 267, 2119 (1992).
19. J J Peschon et al , in preparation.
20. B Thoma, M Grell, K Pfizenmaier, J. Scheurich, J. Exp. Med 172, 1019 (1990); L. A. Tartaglia et al., Proc. Natl. Acad. Sci U S.A. 88, 9292 (1991); L. A. Tartaglia et al., J Immunol. 151, 4637 (1993)
21. B Thoma, M Grell, K Pfizenmaier, J. Scheurich, J. Exp. Med 172, 1019 (1990); L. A. Tartaglia et al., Proc. Natl. Acad. Sci U S.A. 88, 9292 (1991); L. A. Tartaglia et al., J Immunol. 151, 4637 (1993)
22. B Thoma, M Grell, K Pfizenmaier, J. Scheurich, J. Exp. Med 172, 1019 (1990); L. A. Tartaglia et al., Proc. Natl. Acad. Sci U S.A. 88, 9292 (1991); L. A. Tartaglia et al., J Immunol. 151, 4637 (1993)
23. K C.F. Sheehan et al., J. Exp. Med. 181, 607 (1995).
24. J Rothe et al , Nature 364, 798 (1993); K. Pfeffer et al, Cell 73, 457 (1993), S. L Erickson et al, Nature 372, 560 (1994).
25. J Rothe et al , Nature 364, 798 (1993); K. Pfeffer et al, Cell 73, 457 (1993), S. L Erickson et al, Nature 372, 560 (1994).
26. J Rothe et al , Nature 364, 798 (1993); K. Pfeffer et al, Cell 73, 457 (1993), S. L Erickson et al, Nature 372, 560 (1994).
27. Mice were immunized with SRBCs, and frozen sections of spleen were prepared and stained as described in Fig 1 The rat monoclonal antibody MOMA-1 (16) (Serotec) was detected with goat antibody to rat IgG conjugated with biotin (Southern Biotechnology) and HRP-streptavidin (Zymed).
28. G Kraal and M. Janse, Immunology 58, 665 (1986)
29. S. Manathasan et al , J. Inflamm 45, 72 (1995).
30. -/- bone marrow cells, respectively. Ten weeks after bone marrow transfer, mice were immunized with SRBCs. Ten days later, spleen sections were stained with PNA and antibody to IgD as shown in Fig 1.
31. M. Steffen, O G Ottman, M A S Moore, J. Immunol 140, 2621 (1988)
32. M. Worm and R. Geha, Int. Immunol. 6, 1883 (1994).
33. T Kawabe et al., Immunity 1, 167 (1994); J Xu et al., ibid, p 423, B R. Renshaw et al., J. Exp. Med 180, 1889 (1994); N. Ramesh, R Fuleihan, R. Geha, Immunol. Rev. 138, 87 (1994)
34. T Kawabe et al., Immunity 1, 167 (1994); J Xu et al., ibid, p 423, B R. Renshaw et al., J. Exp. Med 180, 1889 (1994); N. Ramesh, R Fuleihan, R. Geha, Immunol. Rev. 138, 87 (1994)
35. T Kawabe et al., Immunity 1, 167 (1994); J Xu et al., ibid, p 423, B R. Renshaw et al., J. Exp. Med 180, 1889 (1994); N. Ramesh, R Fuleihan, R. Geha, Immunol. Rev. 138, 87 (1994)
36. T Kawabe et al., Immunity 1, 167 (1994); J Xu et al., ibid, p 423, B R. Renshaw et al., J. Exp. Med 180, 1889 (1994); N. Ramesh, R Fuleihan, R. Geha, Immunol. Rev. 138, 87 (1994)
37. Animal experiments were conducted in accordance with institutional guidelines for Washington University School of Medicine.
38. We thank J. Cyster for discussions regarding MOMA-1 staining, O Kanagawa and R. Schreiber for critical reading of the manuscript, and B. Wnght and G Huang for assistance with histological evaluations. This work was supported in part by grants from NIH (D.D.C.) and the Monsanto Company (M.H.N.). D.D.C. is an investigator of the Howard Hughes Medical Institute.